Industry news
- Industry news
- Neurology
News of the day
US Educational Support Service for MS Community, MS LifeLines
Geneva, Switzerland, September 1, 2010 - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that MS LifeLines, a US educational and support service which includes a call center, has achieved a milestone in servicing one million in-bound calls since its inception in 2002. MS LifeLines is sponsored by EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, and its co-promotion partner in the US, Pfizer Inc. The service is available to the multiple sclerosis... moreQRxPharma to Sponsor Symposium at International Association for the Study of Pain Meetings
Sydney, Australia and Bedminster, New Jersey -August 31, 2010 -QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today it will sponsor a symposium at the IASP (International Association for the Study of Pain) 13th World Congress of Pain on 31 August, 2010 at Palais des congr morePivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
Raritan, NJ - (August 30, 2010) - Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation. In addition, this study compared oxycodone controlled release (CR) to placebo as an active control. moreIndustry news search
Most Viewed
US Educational Support Service for MS Community, MS LifeLines
European Medicines Agency starts review of Pandemrix
QRxPharma to Sponsor Symposium at International Association for the Study of Pain Meetings
Recent news
To keep up to date with news from this category use our 
European Medicines Agency starts review of Pandemrix
August 27, 2010 --The European Medicines Agency has launched a review of Pandemrix on the request of the European Commission to investigate whether there is a link between cases of narcolepsy and vaccination with...
StemCells, Inc. Reports Breakthrough Using Human Neural Stem Cells to Restore Motor Function in Chronic Spinal Cord Injury
PALO ALTO, Calif., August 19, 2010 - StemCells, Inc. (NASDAQ: STEM), announced today the publication of new preclinical data demonstrating that the Company's proprietary human neural stem cells restore lost motor...
Pluristem's PLX Cells Found to be Effective in Treating Neuropathic and Inflammatory Pain
HAIFA, Israel-- August 09, 2010--Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced the results of two separate pre-clinical studies in animal models which demonstrated that its PLacental...
Orphagen Pharmaceuticals Awarded Phase 2 SBIR Funding to Investigate Novel Drug Class for CNS Disorders
San Diego, February 1, 2010-- Orphagen Pharmaceuticals announced today that it has been awarded a twoyear federal grant to further characterize a novel class of small molecule drugs with potential to treat circadian...
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us